BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33710263)

  • 21. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
    Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
    Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
    JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women.
    Astorg P; Bertrais S; Laporte F; Arnault N; Estaquio C; Galan P; Favier A; Hercberg S
    Eur J Clin Nutr; 2008 Oct; 62(10):1155-61. PubMed ID: 17622261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation.
    Xie L; Innis SM
    J Nutr; 2008 Nov; 138(11):2222-8. PubMed ID: 18936223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between erythrocyte membrane n-3 and n-6 polyunsaturated fatty acids and carotid atherosclerosis: A prospective study.
    Ding D; Zhong QW; Zuo LS; Ling CW; Xiong F; Ke YB; Chen YM
    Atherosclerosis; 2020 Apr; 298():7-13. PubMed ID: 32126389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies.
    Zhu Y; Li M; Rahman ML; Hinkle SN; Wu J; Weir NL; Lin Y; Yang H; Tsai MY; Ferrara A; Zhang C
    PLoS Med; 2019 Sep; 16(9):e1002910. PubMed ID: 31518348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
    Chlebowski RT; Wakelee H; Pettinger M; Rohan T; Liu J; Simon M; Tindle H; Messina C; Johnson K; Schwartz A; Gass M; Wactawski-Wende J
    Clin Lung Cancer; 2016 Jan; 17(1):10-7.e1. PubMed ID: 26577506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
    Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in postmenopausal women is associated with lower erythrocyte PUFA/MUFA and n-3/n-6 ratio: A case-control study.
    Muzsik A; Jeleń HH; Chmurzynska A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Aug; 159():102155. PubMed ID: 32622152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans.
    Kuhnt K; Weiß S; Kiehntopf M; Jahreis G
    Lipids Health Dis; 2016 Feb; 15():32. PubMed ID: 26892399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools.
    Taha AY; Cheon Y; Faurot KF; Macintosh B; Majchrzak-Hong SF; Mann JD; Hibbeln JR; Ringel A; Ramsden CE
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):151-7. PubMed ID: 24675168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients.
    Liu H; Wang F; Liu X; Xie Y; Xia H; Wang S; Sun G
    Lipids Health Dis; 2022 Feb; 21(1):20. PubMed ID: 35144649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.
    Dai XW; Chen YM; Zeng FF; Sun LL; Chen CG; Su YX
    Eur J Nutr; 2016 Apr; 55(3):981-9. PubMed ID: 25935580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous production of
    Sprague M; Xu G; Betancor MB; Olsen RE; Torrissen O; Glencross BD; Tocher DR
    Br J Nutr; 2019 Nov; 122(10):1091-1102. PubMed ID: 31409428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom experience after discontinuing use of estrogen plus progestin.
    Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
    JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PUFA ω-3 and ω-6 biomarkers and sleep: a pooled analysis of cohort studies on behalf of the Fatty Acids and Outcomes Research Consortium (FORCE).
    Murphy RA; Tintle N; Harris WS; Darvishian M; Marklund M; Virtanen JK; Hantunen S; de Mello VD; Tuomilehto J; Lindström J; Bolt MA; Brouwer IA; Wood AC; Senn M; Redline S; Tsai MY; Gudnason V; Eiriksdottir G; Lindberg E; Shadyab AH; Liu B; Carnethon M; Uusitupa M; Djousse L; Risérus U; Lind L; van Dam RM; Koh WP; Shi P; Siscovick D; Lemaitre RN; Mozaffarian D
    Am J Clin Nutr; 2022 Mar; 115(3):864-876. PubMed ID: 34918026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.